Zebrafish as a Model of Neurodevelopmental Disorders.

animal models attention-deficit/hyperactivity disorder autism genetic models neurodevelopment

Journal

Neuroscience
ISSN: 1873-7544
Titre abrégé: Neuroscience
Pays: United States
ID NLM: 7605074

Informations de publication

Date de publication:
01 10 2020
Historique:
received: 19 04 2019
revised: 21 07 2019
accepted: 20 08 2019
pubmed: 1 9 2019
medline: 15 5 2021
entrez: 1 9 2019
Statut: ppublish

Résumé

Neurodevelopmental disorders (NDDs) caused by aberrant brain growth and development are life-long, debilitating illnesses that markedly impair the quality of life. Animal models are a valuable tool for studying NDD pathobiology and therapies. Mounting evidence suggests the zebrafish (Danio rerio) as a useful model organism to study NDDs, possessing both high physiological homology to humans and sensitivity to pharmacological and genetic manipulations. Here, we summarize experimental models of NDDs in zebrafish and highlight the growing translational significance of zebrafish NDD-related phenotypes. We also emphasize the need in further development of zebrafish models of NDDs to improve our understanding of their pathogenesis and therapeutic treatments.

Identifiants

pubmed: 31472215
pii: S0306-4522(19)30607-4
doi: 10.1016/j.neuroscience.2019.08.034
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3-11

Informations de copyright

Copyright © 2019 IBRO. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no conflict of interest.

Auteurs

Murilo S de Abreu (MS)

Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; The International Zebrafish Neuroscience Research Consortium (ZNRC), Slidell, LA, USA. Electronic address: abreu_murilo@hotmail.com.

Rafael Genario (R)

Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil.

Ana C V V Giacomini (ACVV)

Bioscience Institute, University of Passo Fundo (UPF), Passo Fundo, RS, Brazil; Postgraduate Program in Environmental Sciences, University of Passo Fundo, Passo Fundo, Brazil.

Konstantin A Demin (KA)

Institute of Experimental Medicine, Almazov National Medical Research Center, Ministry of Healthcare of Russian Federation, St. Petersburg, Russia; Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia.

Anton M Lakstygal (AM)

Institute of Translational Biomedicine, St. Petersburg State University, St. Petersburg, Russia; Granov Russian Scientific Research Center of Radiology and Surgical Technologies, Ministry of Healthcare of Russian Federation, Pesochny, Russia.

Tamara G Amstislavskaya (TG)

Research Institute of Physiology and Basic Medicine, Novosibirsk, Russia.

Barbara Dotto Fontana (BD)

Brain and Behaviour Laboratory, School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK.

Matthew O Parker (MO)

Brain and Behaviour Laboratory, School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, UK.

Allan V Kalueff (AV)

School of Pharmacy, Southwest University, Chongqing, China; Ural Federal University, Ekaterinburg, Russia. Electronic address: avkalueff@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH